Additionally, further application of spatial transcriptomics technology to in vivo doxorubicin‐tumor response models would allow visualization of the clonal expansion and emergence of ABCB8‐mediated resistance over the time‐course of doxorubicin tumor treatment. The gene discussed is ABCB8; the disease is neoplasm.